Sponsor:
UNC Lineberger Comprehensive Cancer Center
Code:
NCT07634653
Conditions
Leukemia
Acute Leukemia
Acute Lymphoid Leukemia
Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Accepted
Interventions
Exercises
Brief summary:
Conditions
Leukemia
Acute Leukemia
Acute Lymphoid Leukemia
Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Study ID
NCT07634653
Start date
May 1, 2026
Status verified date
Jul, 2026
Completion date
Jun 1, 2028
Anticipated
Primary completion date
Jun 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Accepted
Enrollment
40 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Supportive Care
Arms
experimental: Children with Acute lymphoblastic lymphoma or Acute lymphoblastic leukemia (ALL)
no intervention: Caregivers of Children with Acute lymphoblastic lymphoma or Acute lymphoblastic leukemia (ALL)
Interventions
Exercises
Primary outcome measure
Central contacts
Locations
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
Recruiting
Chapel Hill, North Carolina, United States, 27599
Contacts
Jessica Buddenbaum, MS
jessica_buddenbaum@med.unc.eduPrincipal Investigator:
Thomas Alexander, MD, MPH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Last update posted
Aug 3, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2026-08-03.